Results 31 to 40 of about 5,023,895 (307)
Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress
Kidney & Blood Pressure Research, 2020 Background: Tumor lysis syndrome (TLS) is an oncologic emergency due to a rapid break down of malignant cells usually induced by cytotoxic therapy, with hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia, and serious clinical consequences such ...
J. Matuszkiewicz-Rowińska, J. Małyszko
semanticscholar +1 more source
Hematology. American Society of Hematology. Education Program, 2020 Recent developments in the management of chronic lymphocytic leukemia (CLL) have moved the standard of care away from chemoimmunotherapy to targeted agents such as oral kinase inhibitors or BCL-2 antagonists, alone or in combination with anti-CD20 ...
K. Fischer, O. Al-Sawaf, M. Hallek
semanticscholar +1 more source
Tumor lysis syndrome rare presentation as uremic pericarditis: a case report
, 2023 Tumor lysis syndrome (TLS) is an oncological emergency characterized by the massive destruction of malignant cells and the release of their contents into the extracellular space, which might occur spontaneously or post-chemotherapy.
Pereira, Rafaela +3 more
core +1 more source
Cureus, 2020 Tumor lysis syndrome (TLS) is a life-threatening oncological condition that is typically characterized by metabolic derangements that are often labeled as an acute kidney injury.
Dawood Findakly, R. Luther, Jue Wang
semanticscholar +1 more source
Tumor Lysis Syndrome in a Low-Risk Pancreatic Cancer Patient
Case Reports in Oncology, 2021 Tumor lysis syndrome (TLS) is the most common hematologic emergency encountered during the treatment of high-grade malignancies. While it can lead to death, the prognosis is typically excellent if caught early on in the course.
Paul Travers +2 more
doaj +1 more source
Renal Replacement Therapy, 2023 Background Tumor lysis syndrome is an oncological emergency triggered by the rapid release of intracellular materials from lysed malignant cells. Intensive chemotherapy is challenging for patients with severe renal dysfunction and a high risk of tumor ...
Takahiro Kawaji +8 more
doaj +1 more source
COMPLEMENT-MEDIATED ADIPOCYTE LYSIS BY NEPHRITIC FACTOR SERA [PDF]
, 1993 Recent data indicate a previously unsuspected link between the complement system and adipocyte biology. Murine adipocytes produce key components of the alternative pathway of complement and are able to activate this pathway.
Lachmann, PJ +10 more
core +1 more source
Tumor Lysis Syndrome : Correspondence [PDF]
The Indian Journal of Pediatrics, 2013 To the Editor:We read with interest the management protocol on Tumor lysis syndrome [1] by Rajendran et al. The guidelines are lucid and will be helpful in managing a common emergency in children with malignancies. However, there are a few points which need clarification: Firstly, what should be the choice of fluid for hyperhydration?
Vineeta, Gupta, Sanjeev Kumar, Gupta
openaire +2 more sources
Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
Viruses, 2018 Modern oncotherapy approaches are based on inducing controlled apoptosis in tumor cells. Although a number of apoptosis-induction approaches are available, site-specific delivery of therapeutic agents still remain the biggest hurdle in achieving the ...
Suman Bishnoi +4 more
doaj +1 more source
Case Reports in Gastroenterology, 2020 Tumor lysis syndrome (TLS) is a potentially life-threatening complication of chemotherapy. It usually occurs in rapidly proliferating hematological malignancies. TLS is deemed spontaneous (STLS) when it occurs prior to any cytotoxic or definite treatment.
Inna Shaforostova +4 more
doaj +1 more source